Skip to content

Clinical Trial Of â??Draksha Sharkarâ?? And â??Darvi Amalaki Sharkarâ?? In â??Pittaj Mootrakrichchhraâ??.

Randomized Controlled Clinical Trial To Evaluate Efficacy Of â??Draksha Sharkarâ?? And â??Darvi Amalaki Sharkarâ?? In â??Pittaj Mootrakrichchhraâ??.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018132
Enrollment
60
Registered
2019-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Draksha Sharkar: 20 ml BD (pragbhakta) for 5 days. Control Intervention1: Darvi Amalaki Sharkar: 20 ml BD (pragbhakta) for 5 days.

Sponsors

Sumatibhai Shah Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients presenting with cardinal symptoms of Pittaj mootrakrichchhra mentioned in Charak Samhita, chikitsasthan 26. Such as 1. Sapeetamutrapravrutti 2. Saraktamutra pravrutti 3. Muhurmuhu mutra pravrutti 4. Sadaha Mutrapravritti 5. Sashul Mutrapravritti 2) The patients will be selected irrespective of religion, occupation, economical status and marital status with informed written consent. 3) Patient having above 2 or more than complaints will be selected

Exclusion criteria

Exclusion criteria: Diagnosed patient of 1. Uncontrolled Diabetes Mellitus and Known case of diabetes mellitus 2. TB 3. Renal failure. 4. Patient of chronic cystitis with bladder wall change. 5. Benign or malignant tumors of bladder 6. Known cases of HIV infection. 7. Known case of mutraghat, ashmari (renal, vesicular calculus), benign prostate hypertrophy, urethral stricture, phimosis, tumours, trauma to urogenital tract. 8. Congenital causes and Obstructive pathology

Design outcomes

Primary

MeasureTime frame
1) To assess the efficacy of â??Draksha Sharkarâ?? in â??Pittaj mootrakrichchhraâ?? by clinical parameter (Lakshana). 2) To assess the efficacy of â??Draksha Sharkarâ?? in â??Pittaj mootrakrichchhraâ?? by Routine examination of urine.Timepoint: 5 Days

Secondary

MeasureTime frame
1. To develop evidence based research for efficacy of â??Draksha Sharkarâ?? in â??Pittaj mootrakrichchhraâ?? 2. To generate data of good standardized drug of herbal origin with good efficacy and less side effects. 3. To study the changes in pH of urine with Draksha Sharkar.Timepoint: 5 Days

Countries

India

Contacts

Public ContactRakesh Hingane

Sumatibhai Shah Ayurved Mahavidyalaya

jntayu@gmail.com9822829493

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026